Related Experiment Video
Updated: Feb 25, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants
Marcello Lanari1, Silvia Vandini2, Fulvio Adorni3
1Pediatrics and Neonatology Unit, Imola Hospital, Via Montericco, 4, Imola, Italy. m.lanari@ausl.imola.bo.it.
Insights
Exposure to tobacco smoke during pregnancy, both passive and active, significantly increases infants' risk of hospitalization for bronchiolitis in their first year of life. This highlights the critical need for smoke-free environments for maternal and child respiratory health.
Area of Science:
- Pediatric Respiratory Medicine
- Public Health
- Environmental Health
Background:
- Tobacco smoke exposure (TSE) poses significant risks to maternal and child health, particularly respiratory morbidity in infants.
- Limited birth cohort studies have investigated the impact of prenatal TSE on severe bronchiolitis development.
- Prenatal exposure encompasses both passive and active maternal smoking.
Purpose of the Study:
- To investigate the effects of prenatal and postnatal tobacco smoke exposure on bronchiolitis hospitalization and mortality in the first year of life.
- To assess the association between different levels of maternal smoking and infant respiratory outcomes.
Main Methods:
- A longitudinal, multi-center cohort study conducted in Italy from November 2009 to December 2012.
- Recruitment of newborns born at or after 33 weeks of gestational age (wGA).
- Follow-up of 2,210 newborns during their first year of life to track bronchiolitis hospitalizations.
Main Results:
- 5.4% (120 infants) were hospitalized for bronchiolitis during the first year of life.
- No infant deaths were recorded in the study cohort.
- Prenatal passive TSE and maternal active smoking (>15 cigarettes/day) were significantly associated with increased risk of bronchiolitis hospitalization (adjHR 3.5 and 1.7, respectively).
Conclusions:
- Prenatal exposure to passive and heavy active tobacco smoke detrimentally affects infant respiratory health.
- The study confirms a significant increase in the risk of bronchiolitis hospitalization in the first year of life due to prenatal TSE.
- Findings underscore the importance of smoke-free environments during pregnancy to protect infant respiratory well-being.
Background:
Tobacco smoke exposure (TSE) is a worldwide health problem and it is considered a risk factor for pregnant women's and children's health, particularly for respiratory morbidity during the first year of life. Few significant birth cohort studies on the effect of prenatal TSE via passive and active maternal smoking on the development of severe bronchiolitis in early childhood have been carried out worldwide.
Methods:
From November 2009 to December 2012, newborns born at ≥ 33 weeks of gestational age (wGA) were recruited in a longitudinal multi-center cohort study in Italy to investigate the effects of prenatal and postnatal TSE, among other risk factors, on bronchiolitis hospitalization and/or death during the first year of life.
Results:
Two thousand two hundred ten newborns enrolled at birth were followed-up during their first year of life. Of these, 120 (5.4%) were hospitalized for bronchiolitis. No enrolled infants died during the study period. Prenatal passive TSE and maternal active smoking of more than 15 cigarettes/daily are associated to a significant increase of the risk of offspring children hospitalization for bronchiolitis, with an adjHR of 3.5 (CI 1.5-8.1) and of 1.7 (CI 1.1-2.6) respectively.
Conclusions:
These results confirm the detrimental effects of passive TSE and active heavy smoke during pregnancy for infants' respiratory health, since the exposure significantly increases the risk of hospitalization for bronchiolitis in the first year of life.
More Related Videos
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
10:47Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pulmonary Cycle: Exhalation
Asthma-I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Breathing
Chronic Obstructive Pulmonary Disease-I: Introduction